These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33317787)

  • 1. Immunotherapy induced enterocolitis and gastritis - What to do and when?
    Cheung VTF; Brain O
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101703. PubMed ID: 33317787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal and Hepatic Complications of Immunotherapy: Current Management and Future Perspectives.
    Dougan M
    Curr Gastroenterol Rep; 2020 Mar; 22(4):15. PubMed ID: 32185493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
    Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
    Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.
    Abu-Sbeih H; Wang Y
    Inflamm Bowel Dis; 2020 Apr; 26(5):662-668. PubMed ID: 31560045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis.
    Ibraheim H; Baillie S; Samaan MA; Abu-Sbeih H; Wang Y; Talley NJ; P Jones M; Powell N
    Aliment Pharmacol Ther; 2020 Nov; 52(9):1432-1452. PubMed ID: 32920854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
    Bergqvist V; Hertervig E; Gedeon P; Kopljar M; Griph H; Kinhult S; Carneiro A; Marsal J
    Cancer Immunol Immunother; 2017 May; 66(5):581-592. PubMed ID: 28204866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review.
    Collins M; Soularue E; Marthey L; Carbonnel F
    Clin Gastroenterol Hepatol; 2020 May; 18(6):1393-1403.e1. PubMed ID: 32007539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab.
    Alexander JL; Ibraheim H; Sheth B; Little J; Khan MS; Richards C; Hunter N; Chauhan D; Ratnakumaran R; McHugh K; Pinato DJ; Nathan P; Choy J; Crusz SM; Furness A; Turajlic S; Pickering L; Larkin J; Teare JP; Papa S; Speight A; Sharma A; Powell N
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34233964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe steroid refractory gastritis induced by Nivolumab: A case report.
    Vindum HH; Agnholt JS; Nielsen AWM; Nielsen MB; Schmidt H
    World J Gastroenterol; 2020 Apr; 26(16):1971-1978. PubMed ID: 32390707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.
    Gupta S; Cortazar FB; Riella LV; Leaf DE
    Kidney360; 2020 Feb; 1(2):130-140. PubMed ID: 35372904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system injury from novel cancer immunotherapies.
    Winter SF; Vaios EJ; Dietrich J
    Curr Opin Neurol; 2020 Dec; 33(6):723-735. PubMed ID: 32941192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report.
    Holmstroem RB; Dahl EK; Helms M; Nielsen HV; Andersen JB; Bjerrum JT; Svane IM; Ellebaek E; Seidelin JB
    BMJ Open Gastroenterol; 2022 Dec; 9(1):. PubMed ID: 36581371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.
    Ma C; MacDonald JK; Nguyen TM; Vande Casteele N; Linggi B; Lefevre P; Wang Y; Feagan BG; Jairath V
    Dig Dis Sci; 2022 Apr; 67(4):1128-1155. PubMed ID: 33770330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury in patients treated with immune checkpoint inhibitors.
    Gupta S; Short SAP; Sise ME; Prosek JM; Madhavan SM; Soler MJ; Ostermann M; Herrmann SM; Abudayyeh A; Anand S; Glezerman I; Motwani SS; Murakami N; Wanchoo R; Ortiz-Melo DI; Rashidi A; Sprangers B; Aggarwal V; Malik AB; Loew S; Carlos CA; Chang WT; Beckerman P; Mithani Z; Shah CV; Renaghan AD; Seigneux S; Campedel L; Kitchlu A; Shin DS; Rangarajan S; Deshpande P; Coppock G; Eijgelsheim M; Seethapathy H; Lee MD; Strohbehn IA; Owen DH; Husain M; Garcia-Carro C; Bermejo S; Lumlertgul N; Seylanova N; Flanders L; Isik B; Mamlouk O; Lin JS; Garcia P; Kaghazchi A; Khanin Y; Kansal SK; Wauters E; Chandra S; Schmidt-Ott KM; Hsu RK; Tio MC; Sarvode Mothi S; Singh H; Schrag D; Jhaveri KD; Reynolds KL; Cortazar FB; Leaf DE;
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconceptualization of immune checkpoint inhibitor-associated gastritis.
    Deng YF; Cui XS; Wang L
    World J Gastroenterol; 2024 Sep; 30(36):4031-4035. PubMed ID: 39351252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastrointestinal complications of the new immune checkpoint inhibitor therapies].
    Götze J; Bitzer M; Malek NP
    Dtsch Med Wochenschr; 2019 Dec; 144(24):1731-1736. PubMed ID: 31791080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious immune-related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series.
    Bresteau C; Bonnet P; Robert C; Mussini C; Saiag P; Buecher B; Lebbe C; Allez M; Benamouzig R; Hagège H; Bécheur H; Meyer A; Carbonnel F
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2104-2110. PubMed ID: 37710354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution and recurrence of gastrointestinal immune-related adverse events induced by immune checkpoint inhibitors.
    de Malet A; Antoni G; Collins M; Soularue E; Marthey L; Vaysse T; Coutzac C; Chaput N; Mateus C; Robert C; Carbonnel F
    Eur J Cancer; 2019 Jan; 106():106-114. PubMed ID: 30476730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.
    Velev M; Baroudjian B; Pruvost R; De Martin E; Laparra A; Babai S; Teysseire S; Danlos FX; Albiges L; Bernigaud C; Benderra MA; Pradère P; Zaidan M; Decroisette C; Fallah F; Matergia G; Lavaud P; Jantzem H; Atzenhoffer M; Buyse V; Ammari S; Robert C; Champiat S; Messayke S; Marabelle A; Guettier C; Lebbe C; Lambotte O; Michot JM
    Eur J Cancer; 2023 Jan; 179():28-47. PubMed ID: 36473326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritis.
    Ma BT; Sang LX; Chang B
    World J Gastroenterol; 2024 Jun; 30(24):3123-3125. PubMed ID: 38983955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.